Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry.
Stefanini GG, Cerrato E, Pivato CA, Joner M, Testa L, Rheude T, Pilgrim T, Pavani M, Brouwer J, Lopez Otero D, Munoz Garcia E, Barbanti M, Biasco L, Varbella F, Reimers B, Jimenez Diaz VA, Leoncini M, Salido Tahoces ML, Ielasi A, de la Torre Hernandez JM, Mylotte D, Garot P, Chieffo A, Nombela-Franco L; REVIVAL Investigators. Stefanini GG, et al. Among authors: joner m. JACC Cardiovasc Interv. 2021 Jan 25;14(2):198-207. doi: 10.1016/j.jcin.2020.10.031. JACC Cardiovasc Interv. 2021. PMID: 33478637 Free article.
Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, Fusaro M, Schneider S, Schulz S, Ibrahim T, Ott I, Massberg S, Laugwitz KL, Kastrati A. Tada T, et al. Among authors: joner m. JACC Cardiovasc Interv. 2013 Dec;6(12):1267-74. doi: 10.1016/j.jcin.2013.06.015. JACC Cardiovasc Interv. 2013. PMID: 24355117 Free article.
Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary.
Byrne RA, Serruys PW, Baumbach A, Escaned J, Fajadet J, James S, Joner M, Oktay S, Jüni P, Kastrati A, Sianos G, Stefanini GG, Wijns W, Windecker S. Byrne RA, et al. Among authors: joner m. Eur Heart J. 2015 Oct 7;36(38):2608-20. doi: 10.1093/eurheartj/ehv203. Epub 2015 Jun 12. Eur Heart J. 2015. PMID: 26071600 Free article. Review.
Cerebral Protection During MitraClip Implantation: Initial Experience at 2 Centers.
Frerker C, Schlüter M, Sanchez OD, Reith S, Romero ME, Ladich E, Schröder J, Schmidt T, Kreidel F, Joner M, Virmani R, Kuck KH. Frerker C, et al. Among authors: joner m. JACC Cardiovasc Interv. 2016 Jan 25;9(2):171-9. doi: 10.1016/j.jcin.2015.09.039. Epub 2015 Dec 23. JACC Cardiovasc Interv. 2016. PMID: 26723763 Free article.
The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis.
Jaguszewski M, Aloysius R, Wang W, Bezerra HG, Hill J, De Winter RJ, Karjalainen PP, Verheye S, Wijns W, Lüscher TF, Joner M, Costa M, Landmesser U. Jaguszewski M, et al. Among authors: joner m. JACC Cardiovasc Interv. 2017 Mar 13;10(5):489-499. doi: 10.1016/j.jcin.2016.11.040. JACC Cardiovasc Interv. 2017. PMID: 28279316 Free article. Clinical Trial.
Long-Term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Stents in Routine Practice: 2-Year Results of the ISAR-ABSORB Registry.
Wiebe J, Hoppmann P, Colleran R, Kufner S, Valeskini M, Cassese S, Schneider S, Joner M, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA. Wiebe J, et al. Among authors: joner m. JACC Cardiovasc Interv. 2017 Jun 26;10(12):1222-1229. doi: 10.1016/j.jcin.2017.03.029. JACC Cardiovasc Interv. 2017. PMID: 28641842 Free article.
Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
Kufner S, Joner M, Schneider S, Tölg R, Zrenner B, Repp J, Starkmann A, Xhepa E, Ibrahim T, Cassese S, Fusaro M, Ott I, Hengstenberg C, Schunkert H, Abdel-Wahab M, Laugwitz KL, Kastrati A, Byrne RA; ISAR-DESIRE 4 Investigators. Kufner S, et al. Among authors: joner m. JACC Cardiovasc Interv. 2017 Jul 10;10(13):1332-1340. doi: 10.1016/j.jcin.2017.04.024. JACC Cardiovasc Interv. 2017. PMID: 28683939 Free article. Clinical Trial.
Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.
Byrne RA, Stefanini GG, Capodanno D, Onuma Y, Baumbach A, Escaned J, Haude M, James S, Joner M, Jüni P, Kastrati A, Oktay S, Wijns W, Serruys PW, Windecker S. Byrne RA, et al. Among authors: joner m. EuroIntervention. 2018 Jan 20;13(13):1574-1586. doi: 10.4244/EIJ20170912-01. EuroIntervention. 2018. PMID: 28948934 Free article. Review.
343 results